SI1742608T1 - Bi-aromatiŽŤne spojine, ki aktivirajo receptorje tipa PPAR(GAMA), postopek njihovih izdelav in njihova uporaba v kozmetiŽŤnih ali farmacevtskih zmeseh - Google Patents
Bi-aromatiŽŤne spojine, ki aktivirajo receptorje tipa PPAR(GAMA), postopek njihovih izdelav in njihova uporaba v kozmetiŽŤnih ali farmacevtskih zmesehInfo
- Publication number
- SI1742608T1 SI1742608T1 SI200530933T SI200530933T SI1742608T1 SI 1742608 T1 SI1742608 T1 SI 1742608T1 SI 200530933 T SI200530933 T SI 200530933T SI 200530933 T SI200530933 T SI 200530933T SI 1742608 T1 SI1742608 T1 SI 1742608T1
- Authority
- SI
- Slovenia
- Prior art keywords
- cosmetic
- gamma
- preparation
- pharmaceutical compositions
- type receptors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0404913A FR2869903B1 (fr) | 2004-05-06 | 2004-05-06 | Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppary, leur procede de preparation et leur utilisation dans les compositions cosmetiques ou pharmaceutiques |
US57421704P | 2004-05-26 | 2004-05-26 | |
EP05743226A EP1742608B1 (en) | 2004-05-06 | 2005-04-29 | Biaromatic compounds which activate ppar(gamma) type receptors, their process of preparation and their use in cosmetic or pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1742608T1 true SI1742608T1 (sl) | 2010-04-30 |
Family
ID=34945757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200530933T SI1742608T1 (sl) | 2004-05-06 | 2005-04-29 | Bi-aromatiŽŤne spojine, ki aktivirajo receptorje tipa PPAR(GAMA), postopek njihovih izdelav in njihova uporaba v kozmetiŽŤnih ali farmacevtskih zmeseh |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1742608B1 (sl) |
JP (1) | JP2007536331A (sl) |
KR (1) | KR20070015566A (sl) |
CN (1) | CN1950335A (sl) |
AR (1) | AR048884A1 (sl) |
AT (1) | ATE458468T1 (sl) |
AU (1) | AU2005240345A1 (sl) |
BR (1) | BRPI0510223A (sl) |
CA (1) | CA2563955A1 (sl) |
DK (1) | DK1742608T3 (sl) |
ES (1) | ES2340178T3 (sl) |
FR (1) | FR2869903B1 (sl) |
PL (1) | PL1742608T3 (sl) |
PT (1) | PT1742608E (sl) |
RU (1) | RU2006143054A (sl) |
SI (1) | SI1742608T1 (sl) |
WO (1) | WO2005108352A1 (sl) |
ZA (1) | ZA200609806B (sl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11241420B2 (en) | 2007-04-11 | 2022-02-08 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
US20160331729A9 (en) | 2007-04-11 | 2016-11-17 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
MX2015013374A (es) | 2013-03-20 | 2016-01-08 | Hoffmann La Roche | Derivados de urea y su uso como inhibidores de proteina de uniuon a acidos grasos (puag). |
CN105308020B (zh) * | 2013-03-20 | 2018-01-26 | 豪夫迈·罗氏有限公司 | 脲衍生物及其作为脂肪酸结合蛋白(fabp)抑制剂的用途 |
CN104844476B (zh) * | 2015-04-03 | 2016-08-24 | 李凌 | 一种医药中间体联苯类化合物的合成方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2812876B1 (fr) * | 2000-08-08 | 2002-09-27 | Galderma Res & Dev | Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppar-gamma et leur utilisation dans des compositions cosmetiques ou pharmaceutiques |
MXPA05005334A (es) * | 2002-11-25 | 2005-11-17 | Galderma Res & Dev | Compuestos bifenilo activadores de los receptores de tipo receptores activados de la proliferacion de peroxisoma gamma y su uso en composiciones cosmeticas o farmaceuticas. |
-
2004
- 2004-05-06 FR FR0404913A patent/FR2869903B1/fr not_active Expired - Fee Related
-
2005
- 2005-04-29 KR KR1020067023286A patent/KR20070015566A/ko not_active Application Discontinuation
- 2005-04-29 BR BRPI0510223-5A patent/BRPI0510223A/pt not_active Application Discontinuation
- 2005-04-29 ES ES05743226T patent/ES2340178T3/es active Active
- 2005-04-29 CA CA002563955A patent/CA2563955A1/en not_active Abandoned
- 2005-04-29 SI SI200530933T patent/SI1742608T1/sl unknown
- 2005-04-29 EP EP05743226A patent/EP1742608B1/en active Active
- 2005-04-29 PT PT05743226T patent/PT1742608E/pt unknown
- 2005-04-29 JP JP2007512127A patent/JP2007536331A/ja active Pending
- 2005-04-29 PL PL05743226T patent/PL1742608T3/pl unknown
- 2005-04-29 AU AU2005240345A patent/AU2005240345A1/en not_active Abandoned
- 2005-04-29 RU RU2006143054/04A patent/RU2006143054A/ru unknown
- 2005-04-29 AT AT05743226T patent/ATE458468T1/de active
- 2005-04-29 CN CNA2005800145211A patent/CN1950335A/zh active Pending
- 2005-04-29 DK DK05743226.2T patent/DK1742608T3/da active
- 2005-04-29 WO PCT/EP2005/005797 patent/WO2005108352A1/en active Application Filing
- 2005-05-04 AR ARP050101786A patent/AR048884A1/es unknown
-
2006
- 2006-11-23 ZA ZA200609806A patent/ZA200609806B/en unknown
Also Published As
Publication number | Publication date |
---|---|
PT1742608E (pt) | 2010-04-27 |
ATE458468T1 (de) | 2010-03-15 |
ZA200609806B (en) | 2007-12-27 |
AU2005240345A1 (en) | 2005-11-17 |
CN1950335A (zh) | 2007-04-18 |
AR048884A1 (es) | 2006-06-07 |
JP2007536331A (ja) | 2007-12-13 |
FR2869903B1 (fr) | 2006-06-23 |
ES2340178T3 (es) | 2010-05-31 |
EP1742608B1 (en) | 2010-02-24 |
BRPI0510223A (pt) | 2007-10-23 |
WO2005108352A1 (en) | 2005-11-17 |
RU2006143054A (ru) | 2008-06-20 |
CA2563955A1 (en) | 2005-11-17 |
EP1742608A1 (en) | 2007-01-17 |
DK1742608T3 (da) | 2010-05-17 |
PL1742608T3 (pl) | 2010-07-30 |
KR20070015566A (ko) | 2007-02-05 |
FR2869903A1 (fr) | 2005-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1093967A1 (en) | Novel compounds that modulate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions | |
EP1765379A4 (en) | CO-CRISTAL PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF | |
IL176749A0 (en) | ANTIBODIES TO MAdCAM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
HK1115309A1 (en) | Modified powder and cosmetic composition using same | |
EP1734965A4 (en) | COMPOSITIONS AND METHODS FOR PROVIDING ELEPHANT HYGIENE | |
HK1083835A1 (en) | Novel compounds, pharmaceutical compositions containing same, and methods of use for same | |
HK1093339A1 (en) | Aryl-heteroaromatic products, compositions containing same and use thereof | |
IL173195A0 (en) | Cyclovinylazoline derivatives, their preparation and pharmaceutical compositions containing them | |
IL175300A0 (en) | Indirubin-type compounds, compositions, and methods for their use | |
GB2394894B (en) | New use for pharmaceutical composition | |
HK1086485A1 (en) | Novel compounds, pharmaceutical compositions containing same, and methods of use for same | |
IL186381A (en) | Oxazole canned derivatives and pharmaceuticals and cosmetics containing them | |
IL187391A0 (en) | Thiazole derivatives, their preparation and use and pharmaceutical compositions containing them | |
IL183044A0 (en) | 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof | |
EP1762216A4 (en) | COMPOSITION FOR COSMETIC PREPARATION AND COSMETIC PREPARATION | |
IL179530A0 (en) | Novel compounds, pharmaceutical compositions containing same and methods of use for same | |
IL186258A0 (en) | Chimeric proteins, their preparation and pharmaceutical compositions containing them | |
PL1742608T3 (pl) | Biaromatyczne związki, które aktywują receptory typu PPAR(gamma), sposób ich wytwarzania i ich zastosowanie w kompozycjach kosmetycznych lub farmaceutycznych | |
GB0409542D0 (en) | Cosmetic compositions | |
IL179697A0 (en) | Variants of unc5h2, their preparation and pharmaceutical compositions containing them | |
ZA200406844B (en) | Novel antiinfective compounds, process for their preparation and pharmaceutical compositions containing them | |
EP1683510A4 (en) | COSMETIC COMPOSITION | |
PL376737A1 (pl) | Związki, które modulują receptory typu PPAR<$Egamma> i ich zastosowanie w kompozycjach kosmetycznych lub farmaceutycznych | |
EP1783115A4 (en) | ARYLAMINE KETONES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITIONS WHICH THEY CONTAIN AND ITS APPLICATION | |
IL173507A0 (en) | Chimeric proteins, their preparation and pharmaceutical compositions containing them |